L&T | Bags Orders In The Range Of 2,500-5,000 Cr
\n\nDRL | Gets DCGI Nod For Zytorvi (Toripalimab) In Advanced Esophageal Squamous Cell Carcinoma
\n\nAlert: Zytorvi Is Used For Treatment Of Adult Patients With Esophageal Squamous Cell Carcinoma
\n\nThe shares of LTTS surged over 12% in the opening hour of the day’s trade, making it the top gainer on Nifty 500.
\n\nL&T Tech Svcs, Tatva Chintan shares surge over 7% each on strong Q2 results, Waaree Renewable falls nearly 10% on weak Q2
\n\nThe shares of Reliance jumps nearly 2% ahead of Jio IPO
\n\nMarket opens higher, Nifty above 23,000, Jio IPO in focus, opens today for subscription
\n\nKalpataru Projects Bags Multiple Domestic Orders Worth ₹2,349 Cr In T&D, B&F Businesses
\n\nThe management of UltraTech Cement Ltd., India’s largest cement company expects further price hikes after the festive season and also reiterated its commitment to the ₹1,400 Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) per tonne target by the end of financial year 2028 during its post-earnings conference call.
\n\nHere are five key takeaways from the earnings call
\n\nHere’s a list of stocks in focus going into trade today.
\n\nHere’s a list of stocks in focus going into trade…
Original source: https://www.cnbctv18.com/technology/